P53 immunohistochemical scoring: An independent prognostic marker for patients after hepatocellular carcinoma resection

World Journal of Gastroenterology

Volumn 8, Issue 3, 2002, Pages 459-463

  Qin, Lun Xiu ^a   Tang, Zhao You ^a   Ma, Zeng Chen ^a   Wu, Zhi Quan ^a   Zhou, Xin Da ^a   Ye, Qing Hai ^a   Ji, Yuan ^a   Huang, Li Wen ^a   Jia, Hu Liang ^a   Sun, Hui Chuan ^a   Wang, Lu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYCLINE; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; GENDER; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; REGRESSION ANALYSIS; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL RATE; TUMOR CELL;

EID: 0036282936     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i3.459     Document Type: Article

References (60)

1. Estimates of the worldwide mortality from 25 cancers in 25 cancers in 1990
2. Cancer statistics, 2001
3. Hepatocellular carcinoma - Cause, treatment and metastasis
4. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: With relation to tumor size and invasiveness
5. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
6. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
7. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
8. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients
9. Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers
10. A prospective trial of midwest breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome
11. Prognostic value of p53 protein expression and clinicopathological factors in infiltrating ductal carcinoma of the breast. A study of 192 patients
12. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer
13. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma
14. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia
15. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies
16. Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: Relationship to treatment outcome
17. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: An analysis of medically managed patients
18. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
19. The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma
20. Prognostic impact of P53 status in Ewing sarcoma
21. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting
22. Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer
23. Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci
24. Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: Prognostic significance
25. Circulating p53 antibody in patients with colorectal cancer: Relation to clinicopathologic features and survival
26. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
27. Prognostic factors in tongue cancer - Relative importance of demographic, clinical and histopathological factors
28. P53 determination alongside classical prognostic factors in node-negative breast cancer: An evaluation at more than 10-year follow-up
29. Clinical studies of p53 in treatment and benefit of breast cancer patients
30. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years
31. Expression of p53 and p21waf1/cip1 in gastric carcinoma: Lack of inter-relationship or correlation with prognosis
32. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy
33. p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen
34. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder
35. p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder
36. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma
37. The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma
38. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma
39. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
40. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
41. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan
42. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
43. Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma
44. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
45. Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France
46. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential
47. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97
48. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma
49. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer
50. Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection
51. Recurrence or metastasis of HCC: Predictors, early detection and experimental antiangiogenic therapy
52. Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver
53. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice
54. Expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis
55. Expressions of ICAM and its mRNA in sera and tissues of patients with hepatocellular carcinoma
56. Expressions of chromogranin: A and cathepsin D in human primary hepatocellular carcinoma
57. Clinical significance of serum intercellular adhesion molecule 1 detection in patients with hepatocellular carcinoma
58. Polymorphisms of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma
59. Overexpression of Pgylcoprotein in hepatocellular carcinoma and its clinical implication
60. Immunohistochemical study on p53, H-ras/p21, c-erbB2 protein and PCNA expressio in HCC tissues of Han and minority ethnic patients